Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aspreva Pharmaceuticals Corp
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aspreva Pharmaceuticals Corp since year 2005.
Table 2 shows the detailed insider transactions of Aspreva Pharmaceuticals Corp since 2005.
The reporting company's ticker symbol is ASPV. The reporting company's CIK number is 1314026.
The total value of stock buying since 2005 is $7,650,395.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2005-03-16||Hbm Bioventures Cayman Ltd (10% Owner)||Buy||32,215||12.83||413,415|
|2005-03-09||Hbm Bioventures Cayman Ltd (10% Owner)||Buy||466,000||15.53||7,236,980|
Insider trading activities including stock purchases, stock sales, and option exercises of ASPV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aspreva Pharmaceuticals Corp (symbol ASPV, CIK number 1314026) see the Securities and Exchange Commission (SEC) website.